These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 8447121

  • 1. HTLV-I/II infection is absent among risk groups from Mexico City.
    Islas S, Yamaguchi K, Silva R, Nishimura Y, Kawano F, Ponce M, Barra R, Takatsuki K.
    Vox Sang; 1993; 64(1):57-8. PubMed ID: 8447121
    [No Abstract] [Full Text] [Related]

  • 2. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
    Trejo-Avila LM, Fuentes-Pensamiento R, Scorro Flores-Castañeda M, Diaz-Mendoza ML, Zapata-Benavides P, Tamez-Guerra RS.
    Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
    [Abstract] [Full Text] [Related]

  • 3. A low prevalence of HTLV-I/-II infection among eight population groups from Merida Yucatan, Mexico.
    Gongora-Biachi RA, Gonzalez-Martinez P, Puerto FI, Sosa-Muñoz J, Duarte-Zapata L, Bastarrachea-Ortiz J, Yamaguchi K, Nishimura Y, Takatsuki K.
    J Acquir Immune Defic Syndr (1988); 1992; 5(1):104-6. PubMed ID: 1738082
    [No Abstract] [Full Text] [Related]

  • 4. Seroprevalence of HTLV-I/II in different groups at risk in northeast Mexico.
    Zapata-Benavides P, Lara-Rodríguez MA, Alcocer-González JM, Rodríguez-Padilla C, Taméz-Guerra R, Trejo-Avila LM.
    Vox Sang; 1996; 70(3):181-2. PubMed ID: 8740014
    [No Abstract] [Full Text] [Related]

  • 5. [Lymphotropic viruses type I and II in pregnant women in Yucatán].
    Góngora-Biachi RA, González-Martínez P, Castro-Sansores C, Vivas-Rosel ML, Gasque-López F, Garrido-Hadad E.
    Rev Invest Clin; 1996; 48(5):383-4. PubMed ID: 9005516
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of and risk factors for HTLV-I and HTLV-II infection among patients at a hospital in the south Bronx, New York.
    Factor SH, Irwin KL, Lal RB, Rudolph D, Weber JT, Olivo N, Ernst J.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug 01; 12(4):431-2. PubMed ID: 8673556
    [No Abstract] [Full Text] [Related]

  • 7. Absence of HTLV-I infection in patients with malignancy in the Yucatan peninsula.
    Góngora-Biachi RA, González-Martínez P, Puerto FI, Bastarrachea-Ortíz J, Yamaguchi K, Nishimura Y, Takatsuki K.
    Rev Invest Clin; 1993 Aug 01; 45(3):281-2. PubMed ID: 8210771
    [No Abstract] [Full Text] [Related]

  • 8. [Infection by human T-cell lymphotropic virus type I/II in polytransfused patients in the state of Yucatán, Mexico].
    González-Martínez P, Castro-Sansores C, Vivas-Rosel ML, Góngora-Biachi RA.
    Sangre (Barc); 1994 Feb 01; 39(1):45-8. PubMed ID: 7910984
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of antibodies to HTLV-I/II in blood donors and risk populations in South China.
    Cao F, Ji Y, Huang R, Lin S.
    Vox Sang; 1998 Feb 01; 75(2):154. PubMed ID: 9784671
    [No Abstract] [Full Text] [Related]

  • 10. [Prevalence of HTLV-I/II infection in various population groups in Gran Canaria].
    Evora Santana O, Rodríguez E, del Pino Reyes M, Martín Sánchez AM.
    Med Clin (Barc); 1999 Feb 20; 112(6):237. PubMed ID: 10191490
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence of human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) in selected Tijuana subpopulations.
    Guerena-Burgueno F, Benenson AS, Sepulveda-Amor J, Ascher MS, Vugia DJ, Gallo D.
    Am J Trop Med Hyg; 1992 Aug 20; 47(2):127-32. PubMed ID: 1503181
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HTLV-I and HTLV-II infections in French blood donors.
    Couroucé AM, Pillonel J, Lemaire JM.
    Vox Sang; 1993 Aug 20; 65(4):334. PubMed ID: 8310688
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.